Apolipoprotein A-I Assay by Randox Laboratories Ltd.
Manufacturer Randox Laboratories Ltd.
The main role of Apolipoprotein A-I (Apo A-I) is in the removal of excess cholesterol from extra-hepatic tissues.Like HDL Cholesterol Apo A-I can be described as non-atherogenic showing an inverse relationship to cardiovascular disease risk. Individuals with cardiovascular disease generally have reduced levels of Apo A-I and increased levels of Apo B. The Randox Apo A-I assay is based on an immunoturbidimetric method. All reagents are liquid ready-to-use and suitable for use on a wide range of ... Read more
The supplier does not provide quotations for this product through SelectScience. Browse these related products instead
Related Products
.jpg.ashx?width=100&height=100&bgcolor=white)
Apolipoprotein A-I Assay
The main role of Apolipoprotein A-I (Apo A-I) is in the removal of excess cholesterol from extra-hepatic tissues.
Like HDL Cholesterol Apo A-I can be described as non-atherogenic showing an inverse relationship to cardiovascular disease risk. Individuals with cardiovascular disease generally have reduced levels of Apo A-I and increased levels of Apo B. The Randox Apo A-I assay is based on an immunoturbidimetric method. All reagents are liquid ready-to-use and suitable for use on a wide range of chemistry analysers.
Like HDL Cholesterol Apo A-I can be described as non-atherogenic showing an inverse relationship to cardiovascular disease risk. Individuals with cardiovascular disease generally have reduced levels of Apo A-I and increased levels of Apo B. The Randox Apo A-I assay is based on an immunoturbidimetric method. All reagents are liquid ready-to-use and suitable for use on a wide range of chemistry analysers.
Product Overview
